Cardamonin induces ros-mediated g2/m phase arrest and apoptosis through inhibition of nf-κb pathway in nasopharyngeal carcinoma

48Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cardamonin has been demonstrated to have an inhibitory effect in many cancers, but its underlying mechanism remains elusive. Here, we studied, for the first time, the mechanism of cardamonin-induced nasopharyngeal carcinoma cell death both in vitro and in vivo. In our study, we showed that cardamonin inhibited cancer cell growth by inducing G2/M phase cell cycle arrest and apoptosis via accumulation of ROS. NF-κB activation was involved in breaking cellular redox homeostasis. Therefore, our results provided new insight into the mechanism of the antitumor effect of cardamonin, supporting cardamonin as a prospective therapeutic drug in nasopharyngeal carcinoma by modulating intracellular redox balance.

Cite

CITATION STYLE

APA

Li, Y., Qin, Y., Yang, C., Zhang, H., Li, Y., Wu, B., … Wu, G. (2017). Cardamonin induces ros-mediated g2/m phase arrest and apoptosis through inhibition of nf-κb pathway in nasopharyngeal carcinoma. Cell Death and Disease. Springer Nature. https://doi.org/10.1038/cddis.2017.407

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free